Implementing a Review Process to Facilitate and Prioritize COVID-19 Research: Staying One Step Ahead of the Pandemic

Abstract

The first coronavirus disease 2019 (COVID-19) patient in the state of New Jersey (NJ) was admitted on March 2, 2020. With the number of hospitalized patients increasing exponentially in the following days and no established treatment approaches, research was to play a significant role in this fight. To facilitate review of all COVID-19 research proposals in a large health care network in NJ, we established the COVID-19 Research Review Committee (RRC) and implemented a peer-review process prior to the Institutional Review Board submission. The RRC was tasked with processing, soliciting, reviewing, and prioritizing research proposals and was comprised of a multidisciplinary group of reviewers. Within a 9-week period, three network-wide requests for proposals were released with 238 proposals submitted and 93 approved, an approval rate of 39%. The establishment of the RRC helped ensure scientific merit, better utilization of resources, collaborations across disciplines and network hospitals, and compliance with applicable regulatory and ethical standard.

Keywords

research review COVID-19 research Research Review Committee

Get full access to this article

View all access options for this article.

References

Dominus

(2020). How New Jersey’s First Coronavirus Patient Survived. The New York Times Magazine . Retrieved June 11, 2020. https://www.nytimes.com/2020/04/05/magazine/first-coronavirus-patient-new-jersey.html

Harris

P. A.

Taylor

Minor

B. L.

Elliott

Fernandez

O’Neal

McLeod

Delacqua

Kirby

Duda

S. N.

, REDCap Consortium. (2019). The REDCap consortium: Building an international community of software partners. Journal of Biomedical Informatics, 95, 103208. https://doi.org/10.1016/j.jbi.2019.103208

Harris

P. A.

Taylor

Thielke

Payne

Gonzalez

Conde

J. D.

(2009). Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377-381. https://doi.org/10.1016/j.jbi.2008.08.010

Mehra

M. R.

Desai

S. S.

Kuy

Henry

T. D.

Patel

A. N.

(2020b). Cardiovascular disease, drug therapy, and mortality in COVID-19. The New England Journal of Medicine, 382(25), e102. https://doi.org/10.1056/NEJMoa2007621 (Retraction published N Engl J Med. 2020 Jun 4) https://pubmed.ncbi.nlm.nih.gov/

Mehra

M. R.

Desai

S. S.

Ruschitzka

Patel

A. N.

(2020a). Retracted: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis. Lancet (London, England), S0140-6736(20)31180-6. Advance online publication. https://doi.org/10.1016/S0140-6736(20)31180-6 (Retraction published Lancet. 2020 Jun 5).

National Center for Biotechnology Information. PubMed . Retrieved June 9, 2020 from https://pubmed.ncbi.nlm.nih.gov/